GuidePoint Security Wins 2025 CrowdStrike Global Solution Provider of the Year Award
Company Recognized for Excellence in Delivering Falcon Next-Gen SIEM and Helping Organizations Strengthen Cybersecurity LAS VEGAS–(BUSINESS WIRE)–#cyber–Fal.Con... Read more.
Apollo Therapeutics’ Anti-IL-18 Antibody Camoteskimab Met the Primary Endpoint in a Double-Blind, Randomized, Placebo-Controlled Phase 2a Clinical Trial in Atopic Dermatitis
Patients receiving camoteskimab had a clinically meaningful and statistically significant reduction in mean EASI score at week 16 compared to placebo. Clear separation... Read more.
ESA’s Skimsat VLEO Mission Moves forward with Redwire Primeship in Cooperation with Thales Alenia Space
PARIS–(BUSINESS WIRE)–$RDW–Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that it... Read more.
William Blair Adds Nordics Managing Director Focused on Private Equity
LONDON & STOCKHOLM–(BUSINESS WIRE)–William Blair announced today the expansion of the firm’s private equity coverage in the Nordics with the addition... Read more.
Mogo Announces Appointment of Joanna Floyd to Board of Directors
VANCOUVER, British Columbia–(BUSINESS WIRE)–Mogo Inc. (NASDAQ: MOGO; TSX: MOGO), a digital wealth, payments, and Bitcoin company, today announced the... Read more.
VFC INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that V.F. Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of V.F. Corporation. (NYSE: VFC)... Read more.
AccurKardia Announces Clinical Pilot Study of Its AK+ Guard ECG-based, AI-powered Hyperkalemia Detection Software
NEW YORK–(BUSINESS WIRE)–#AIinHealthcare—AccurKardia, an innovator in ECG-based diagnostics technology, has announced the initiation of a multicenter... Read more.
Charles River Laboratories Announces Chief Financial Officer Transition
– Michael G. Knell, Corporate Senior Vice President & Chief Accounting Officer, Appointed Interim CFO by the Board of Directors – – Company Reaffirms 2025... Read more.
Cook MyoSite and Veristat Partner in Complex, Phase III, Adaptive Clinical Study of Investigational Cell Therapy for Unmet Need in Women’s Health
Veristat partners to achieve key enrollment milestone for study; activated 26 sites and enrolled more than 100 participants SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–#Veristat—Veristat,... Read more.
4th Annual Survey of Limited Partners Suggests Big Plans for Alts & Tech, GP-LP Relationship Entering New Phase
LPs Favor Co-investments, Adjust Geographic Focus, and Apply a Critical Lens to Technology BOSTON–(BUSINESS WIRE)–#AlternativeInvestments–Now in... Read more.